Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01886794 · ClinicalTrials.gov registry record · Phase 4
Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse
A Phase 4 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT01886794: Clinical Trial Phase 4 study, sponsored by The University of Texas Medical Branch, Galveston.
NCT01886794 is a Phase 4 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 7 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01886794, a Phase 4 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
Our primary aim in the current study is to determine important tissue differences, including muscle and connective tissue changes, between postmenopausal women and reproductive age women with pelvic floor dysfunction to help develop targeted and noninvasive treatments.
Primary Outcome
Measure of vaginal epithelial thickness obtained by optical coherence tomography
Interventions
- DRUG Postmenopausal, topical vaginal estrogen cream
- DRUG Placebo Comparator: Postmenopausal, topical placebo cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-06-06 |
| Est. Completion | 2023-12-11 |
| Phase | Phase 4 |
Why NCT01886794 stopped before completion
NCT01886794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Postmenopausal, topical vaginal estrogen cream is the first listed.
NCT01886794 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01886794 about?
NCT01886794 is a clinical study titled "Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse". Our primary aim in the current study is to determine important tissue differences, including muscle and connective tissue changes, between postmenopausal women and reproductive age women with pelvic floor dysfunction to help develop targeted and noninvasive treatments.
What is the current status of trial NCT01886794?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2013-06-06. Estimated completion is 2023-12-11.
What interventions are being tested in trial NCT01886794?
The interventions under investigation include: Postmenopausal, topical vaginal estrogen cream (DRUG), Placebo Comparator: Postmenopausal, topical placebo cream (DRUG).
Who is sponsoring clinical trial NCT01886794?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01886794's enrollment target sits among peer trials
7 1981st of 2000 higher than 18 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI